We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.54% | 1.65 | 1.60 | 1.70 | 1.70 | 1.625 | 1.63 | 27,752,936 | 15:13:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.74 | 8.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2021 10:31 | Do you think this is a placing? | maxplus2 | |
09/2/2021 10:26 | What are the sales figures so far? | breezy4 | |
09/2/2021 10:17 | So many that have read this RNS loading up with shares as middle of month gets closer even these parts of the RNS Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | bunz3 | |
09/2/2021 10:11 | Only got to double from here and we are back to last years 52 week high, but now we have a tie up in motion | awise355 | |
09/2/2021 09:58 | 129 paid ,important in my view any sellers cleared before 1,30 , when they cleared then a move up to 1,50 likely this reminds me so much of ncyt as it moved up from around £2,20 to £12 | bunz3 | |
09/2/2021 09:50 | Looking very strong now. £2 just around the corner | wapper | |
09/2/2021 09:40 | One that confuses me, why have BGF have reduced their shareholding with the promising partnership with Beckman Coulter | maxplus2 | |
09/2/2021 09:36 | Time to move up again | stumbleupon | |
09/2/2021 09:29 | Is another move up building up again | bunz3 | |
09/2/2021 08:55 | when one looks at how soon any sells are bought up ,looks like so many buyers wanting shares , £2 likely to be seen soon as more look to be buying in before Mid February | bunz3 | |
09/2/2021 08:49 | This signed deal with Beckman Coulter will be massive. We're looking at a multi bagger here.....imo | swerves1 | |
09/2/2021 08:38 | Good to see buyers out again...£2 I agree looks possible in run up to the next bit of news DYOR | qs99 | |
09/2/2021 08:31 | Could hit 2 by Friday | swerves1 | |
09/2/2021 08:30 | 125 paid already | bunz3 | |
09/2/2021 08:28 | 150 coming!!! Choo choo | losses | |
09/2/2021 08:28 | up to 1,22 already | bunz3 | |
09/2/2021 08:26 | Bloomberg confirmed seller cleared. Swift move above £2 before news as it was BGF holding share price back. Brakes are off Strong Buy | seball | |
09/2/2021 08:24 | they moving share price up nicely now 121 paid | bunz3 | |
09/2/2021 08:16 | 119 being paid ,looking strong | bunz3 | |
09/2/2021 08:11 | another nice buy | bunz3 | |
09/2/2021 08:07 | Chunky buy | bunz3 | |
09/2/2021 08:00 | Strong start this morning | bunz3 | |
08/2/2021 23:51 | Come back syme | professor_kemche | |
08/2/2021 23:50 | if BGF now out be an interesting day Tomorrow | bunz3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions